CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Israel

4 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06920004
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Trial Treatment · Phase 3 · argenx
The Barzilai University Medical Center, Ashkelon · Hadassah Medical Center - Ein Kerem, Jerusalem · The Chaim Sheba Medical Center, Tel-Hashomer
Registry updated 2026-11-03
NCT06858579
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Cinical Study Site, Beersheba · Cinical Study Site, Haifa · Cinical Study Site, Safed
Registry updated 2026-10-28
NCT07091630
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Trial Treatment · Phase 3 · argenx
Hillel Yaffe Medical Center, Hadera · The Chaim Sheba Medical Center - PPDS, Ramat Gan
Registry updated 2026-10-27
NCT06290141
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 3 · Sanofi
Investigational Site Number : 3760001, Haifa
Registry updated 2026-10-19

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP